Social engagement
Social engagement: 18.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Arch Venture Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 54% |
| Private equity | 1 | 8% |
| Other / undisclosed | 5 | 38% |
Recent activity
17 Sep 2025
Milestone
anniversary
16 Sep 2025
Event
ASCENT2025 panel discussion on circular RNA for in vivo CAR-T therapy and innovation in mRNA cancer immunotherapies
4 Sep 2025
Leadership hire
Senior Vice President, Clinical Development